Standardisation and reporting for nucleic acid quantification

Accreditation and Quality Assurance

Volumn 16, Issue 8, 2011, Pages 399-405

  Huggett, Jim ^a   Bustin, Stephen A ^b,c  

^a LGC   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

DNA; FRET; Pathogen; Quantification; Real time polymerase chain reaction; RNA

Indexed keywords

EID: 79961014660     PISSN: 09491775     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00769-011-0769-y     Document Type: Review

References (46)

1. Bustin SA (2004) A-Z of quantitative PCR. IUL Press, La Jolla.
2. Reuter T, Gilroyed BH, Alexander TW, Mitchell G, Balachandran A, Czub S, McAllister TA (2009) Prion protein detection via direct immuno-quantitative real-time PCR. J Microbiol Methods 78: 307-311.
3. Morrison TB, Weis JJ, Wittwer CT (1998) Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-962.
4. Ririe KM, Rasmussen RP, Wittwer CT (1997) Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 245: 154-160.
5. Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6: 986-994.
6. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP (1997) Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22: 130-138.
7. Marras SA, Tyagi S, Kramer FR (2006) Real-time assays with molecular beacons and other fluorescent nucleic acid hybridization probes. Clinica Chimica Acta 363: 48-60.
8. Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193.
9. Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23-39.
10. Bustin SA, Nolan T (2004) Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 15: 155-166.
11. Bustin SA, Benes V, Nolan T, Pfaffl MW (2005) Quantitative real-time RT-PCR-a perspective. J Mol Endocrinol 34: 597-601.
12. Nolan T, Hands RE, Bustin SA (2006) Quantification of mRNA using real-time RT-PCR. Nat Protoc 1: 1559-1582.
13. Bustin SA, Mueller R (2005) Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond). 109: 365-379.
14. Bustin SA (2006) Nucleic acid quantification and disease outcome prediction in colorectal cancer. Personalized Medicine 3: 207-216.
15. Bustin SA, Mueller R (2006) Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer. Mol Aspects Med 27: 192-223.
16. Murphy J, Dorudi S, Bustin SA (2007) Molecular staging of colorectal cancer: new paradigm or waste of time? Expert Opin Med Diagn 1: 31-45.
17. Bustin S (2008) Molecular medicine, gene-expression profiling and molecular diagnostics: putting the cart before the horse. Biomarkers in Medicine 2: 201-207.
18. Bustin SA (2008) Real-time quantitative PCR-opportunities and pitfalls. European Pharmeceutical Review 4: 18-23.
19. Bustin SA (2008) Real-time polymerase chain reaction-towards a more reliable, accurate and relevant assay. European Pharmeceutical Review 6: 19-27.
20. Murphy J, Bustin SA (2009) Reliability of real-time reverse-transcription PCR in clinical diagnostics: gold standard or substandard? Expert Rev Mol Diagn 9: 187-197.
21. Bustin SA (2010) Why the need for qPCR publication guidelines?-The case for MIQE. Methods 50: 217-226.
22. Perez-Novo CA, Claeys C, Speleman F, van Cauwenberge P, Bachert C, Vandesompele J (2005) Impact of RNA quality on reference gene expression stability. Biotechniques 39: 52-56.
23. Fleige S, Pfaffl MW (2006) RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 27: 126-139.
24. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW (2006) Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 28: 1601-1613.
25. Nolan T, Hands RE, Ogunkolade BW, Bustin SA (2006) SPUD: a qPCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem 351: 308-310.
26. Huggett J, Dheda K, Bustin S, Zumla A, Real-time RT-PCR (2005) normalisation; strategies and considerations. Genes Immun 6: 279-284.
27. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Bustin SA, Orlando C (2002) Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309: 293-300.
28. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A (2004) Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37: 112-119.
29. Vandesompele J, De Preter K, Pattyn F, Poppe B, van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: 0034. 1-0034. 11.
30. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26: 509-515.
31. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
32. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, Johnson MA, Rook GA, Zumla A (2005) The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem 344: 141-143.
33. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB, Walker-Smith J, Thomson M, Wakefield AJ, O'Leary JJ (2002) Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 55: 84-90.
34. Bustin SA (2008) RT-qPCR and molecular diagnostics: no evidence for measles virus in the GI tract of autistic children. Eur Pharm Rev Dig 1: 11-16.
35. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, Hummel K, Rota PA, Bellini WJ, O'Leary JJ, Sheils O, Alden E, Pickering L, Lipkin WI (2008) Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS ONE 3: e3140.
36. Afzal MA, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, Minor PD (2006) Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 78: 623-630.
37. D'Souza Y, Fombonne E, Ward BJ (2006) No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 118: 1664-1675.
38. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT, The MIQE (2009) guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
39. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2011) Primer sequence disclosure: a clarification of the MIQE guidelines. Clin Chem (in press).
40. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. NatGenet 29: 365-371.
41. Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK Jr, Jones AR, Zhu W, Apweiler R, Aebersold R, Deutsch EW, Dunn MJ, Heck AJ, Leitner A, Macht M, Mann M, Martens L, Neubert TA, Patterson SD, Ping P, Seymour SL, Souda P, Tsugita A, Vandekerckhove J, Vondriska TM, Whitelegge JP, Wilkins MR, Xenarios I, Yates JR 3rd, Hermjakob H (2007) The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 25: 887-893.
42. Field D, Garrity G, Gray T, Morrison N, Selengut J, Sterk P, Tatusova T, Thomson N, Allen MJ, Angiuoli SV, Ashburner M, Axelrod N, Baldauf S, Ballard S, Boore J, Cochrane G, Cole J, Dawyndt P, De Vos P, DePamphilis C, Edwards R, Faruque N, Feldman R, Gilbert J, Gilna P, Glockner FO, Goldstein P, Guralnick R, Haft D, Hancock D, Hermjakob H, Hertz-Fowler C, Hugenholtz P, Joint I, Kagan L, Kane M, Kennedy J, Kowalchuk G, Kottmann R, Kolker E, Kravitz S, Kyrpides N, Leebens-Mack J, Lewis SE, Li K, Lister AL, Lord P, Maltsev N, Markowitz V, Martiny J, Methe B, Mizrachi I, Moxon R, Nelson K, Parkhill J, Proctor L, White O, Sansone SA, Spiers A, Stevens R, Swift P, Taylor C, Tateno Y, Tett A, Turner S, Ussery D, Vaughan B, Ward N, Whetzel T, San Gil I, Wilson G, Wipat A (2008) The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol 26: 541-547.
43. Haney SA (2007) Increasing the robustness and validity of RNAi screens. Pharmacogenomics 8: 1037-1049.
44. Sansone SA, Fan T, Goodacre R, Griffin JL, Hardy NW, Kaddurah-Daouk R, Kristal BS, Lindon J, Mendes P, Morrison N, Nikolau B, Robertson D, Sumner LW, Taylor C, van der Werf M, van Ommen B, Fiehn O (2007) The metabolomics standards initiative. Nat Biotechnol 25: 846-848.
45. Taylor CF, Field D, Sansone SA, Aerts J, Apweiler R, Ashburner M, Ball CA, Binz PA, Bogue M, Booth T, Brazma A, Brinkman RR, Michael Clark A, Deutsch EW, Fiehn O, Fostel J, Ghazal P, Gibson F, Gray T, Grimes G, Hancock JM, Hardy NW, Hermjakob H, Julian RK Jr, Kane M, Kettner C, Kinsinger C, Kolker E, Kuiper M, Novere NL, Leebens-Mack J, Lewis SE, Lord P, Mallon AM, Marthandan N, Masuya H, McNally R, Mehrle A, Morrison N, Orchard S, Quackenbush J, Reecy JM, Robertson DG, Rocca-Serra P, Rodriguez H, Rosenfelder H, Santoyo-Lopez J, Scheuermann RH, Schober D, Smith B, Snape J, Stoeckert CJ Jr, Tipton K, Sterk P, Untergasser A, Vandesompele J, Wiemann S (2008) Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 26: 889-896.
46. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, Penning LC, Toegel S (2010) MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 11: 74.